Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Systematic approach to developing splice modulating antisense oligonucleotides
37 Bydureon Pen (AstraZeneca, Wilmington, DE, USA) and Bydureon BCise (AstraZeneca) were developed later, but currently, only the latter, an enhanced injector pen formulation, is prescribed
This study provides valuable insights into the molecular mechanisms of cognitive impairment in T2DM
The Lancet (2022) 13
US$ 27.42
US$ 27.42
US$ 21.74
US$ 24.32
US$ 21.71
US$ 28.29
US$ 27.22
